Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

BOM/543828 stock hub

BOM/543828 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/543828is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

7.3B

Bombay Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BOM/543828

In the news

Latest news · BOM/543828

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E31.2

P25 n/aP50 n/aP75 n/a

ROE16.2

P25 n/aP50 n/aP75 n/a

ROIC10.8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/543828 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

192

Groups with data

Currency

INR

Showing 192 of 192 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	60
Employees Change	4%
Employees Change Percent	7.14
Enterprise value	INR 10.1B
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	INR 7.3B
Price	INR 30.3
Price currency	INR
Rev Per Employee	118,628,250x
Sic	2834
Symbol	bom/543828
Website	https://www.sudarshanpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.2%
EV Earnings	43.53x
EV/EBIT	18.04x
EV/EBITDA	16.9x
EV/FCF	-14.21x
EV/Sales	1.43x
FCF yield	-9.79%
P/B ratio	4.66x
P/E ratio	31.24x
P/S ratio	1.02x
PE Ratio3 Y	37.76x
PE Ratio5 Y	35.9x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	7.9%
EBITDA Margin	8.43%
Gross margin	12.98%
Gross Profit	INR 923.9M
Gross Profit Growth	41.69%
Gross Profit Growth Q	146.69%
Gross Profit Growth3 Y	44.9%
Net Income	INR 233M
Net Income Growth	46.06%
Net Income Growth Q	272.18%
Net Income Growth3 Y	49.06%
Pretax Margin	4.29%
Profit Margin	3.27%
Profit Per Employee	INR 3.9M
ROA	6.73
Roa5y	5.87
ROCE	30.3
ROE	16.24
Roe5y	14.19
ROIC	10.8
Roic5y	11.52

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	14.65%
Cagr3y	63.94%
EPS Growth	46.97
EPS Growth Q	291.7
EPS Growth3 Y	49.14
Revenue Growth	40.93x
Revenue Growth Q	94.58x
Revenue Growth3 Y	15.55x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	INR 1.36
Assets	INR 6.4B
Cash	INR 11.3M
Current Assets	INR 4.9B
Current Liabilities	INR 4.6B
Debt	INR 2.9B
Debt EBITDA	INR 4.75
Debt Equity	INR 1.82
Debt FCF	INR -3.99
Equity	INR 1.6B
Interest Coverage	2.19
Liabilities	INR 4.9B
Long Term Assets	INR 1.5B
Long Term Liabilities	INR 293.1M
Net Cash	INR -2.8B
Net Cash By Market Cap	INR -38.93
Net Debt EBITDA	INR 4.73
Net Debt Equity	INR 1.82
Tangible Book Value	INR 1.4B
Tangible Book Value Per Share	INR 6.26
WACC	8.24

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.07
Inventory Turnover	3.45
Net Working Capital	INR 2.9B
Quick ratio	0.51
Working Capital	INR 341.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.62%
Dividend per share	INR 0
Last Dividend	INR 0.03

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	14.64%
200-day SMA	26.95
3Y total return	340.75%
50-day SMA	27.42
50-day SMA vs 200-day SMA	50over200
All Time High	53.5
All Time High Change	-43.36%
All Time High Date	2025-01-07
All Time Low	5.19
All Time Low Change	484.38%
All Time Low Date	2023-03-31
ATR	1.18
Beta	0.82
Beta1y	0.76
Beta2y	0.41
Ch YTD	9.98
High	31
High52	35.19
High52 Date	2025-08-25
High52ch	-13.9%
Low	30.12
Low52	18.5
Low52 Date	2026-01-29
Low52ch	63.78%
Ma50ch	10.52%
Price vs 200-day SMA	12.45%
RSI	59.85
RSI Monthly	55.76
RSI Weekly	57.26
Sharpe ratio	0.42x
Sortino ratio	0.75
Total Return	0.62%
Tr YTD	9.98
Tr1m	4.56%
Tr1w	-2.23%
Tr3m	19.48%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 562.4M
Operating Income Growth	46.36
Operating Income Growth Q	216.3
Operating Income Growth3 Y	57.8
Operating margin	7.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	89,581,290%
Net Borrowing	1,038,280,000
Shares Insiders	59.09%
Shares Institutions	17.57%
Shares Out	240,658,870
Shares Qo Q	-5.72%
Shares Yo Y	-0.62%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	INR -714M
Average Volume	207,800x
Bv Per Share	6.94
CAPEX	INR -691M
Ch1m	4.56
Ch1w	-2.23
Ch1y	14.64
Ch3m	19.48
Ch3y	339.1
Ch6m	5.91
Change	0.97%
Change From Open	-0.95
Close	30.01
Days Gap	1.93
Depreciation Amortization	37,883,000
Dollar Volume	1,939,200
Earnings Date	2026-04-30
EBIT	INR 562.4M
EBITDA	INR 600.3M
EPS	INR 0.97
F Score	3
FCF	INR -714M
FCF EV Yield	-7.04x
FCF Per Share	INR -2.97
Financing CF	791,692,000
Fiscal Year End	March
Founded	2,008
Goodwill	52,201,000
Graham Number	12.30766
Graham Upside	-59.38
Income Tax	INR 71.7M
Investing CF	-776,966,000
Is Primary Listing	1
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Last Split Date	2024-11-22
Last Split Type	Forward
Lynch Fair Value	INR 24.25
Lynch Upside	-19.97
Ma150	25.84
Ma150ch	17.25%
Ma20	30.39
Ma20ch	-0.3%
Net CF	5,843,000
Open	30.59
Position In Range	20.45
Ppne	808,478,000
Price Date	2026-05-08
Price EBITDA	INR 12.15
Ptbv Ratio	5.21
Relative Volume	0.31x
Revenue	7,117,695,000x
Tax By Revenue	1.01x
Tax Rate	23.47%
Tr6m	5.91%
Volume	64,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BOM/543828 pay a dividend?

Capital-return profile for this ticker.

Performance

BOM/543828 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BOM/543828?

Insider, institutional, and short-interest positioning.

Institutional ownership

+17.6%

Share of float held by funds and institutions

Insider ownership

+59.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.6%

Negative means the company is buying back shares.

Technical

BOM/543828 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

59.8

Neutral momentum band

Price vs 200-day MA

+12.4%

50/200-day relationship not available

Beta (5Y)

0.82

Moves roughly with the market

Sharpe ratio

0.42

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/543828

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/543828 stock rating?

bom/543828 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/543828 analysis?

The full report lives at /stocks/bom/543828/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/543828?

The latest report frames bom/543828 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/543828 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.